B+
Bull case
15%
Probability
Target price
$26.88
-14.8% vs current
TNGX
Tango TherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-11
AI scenario view
RankAlpha Sentiment AIMost likely
B
Base case
55%
Probability
Target price
$15.50
-50.9% vs current
B-
Bear case
30%
Probability
Target price
$10.10
-68.0% vs current
AI sentiment snapshot
Latest data as of 2026-03-07
Recent news sentiment (30D)
-
Unavailable
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Sentiment proxy
0.0
Score
AI commentary
Sentiment is mixed: analyst targets cluster in the mid‑teens while a subset of higher outliers creates dispersion and episodic volatility [#SERP-3]. The analyst median sits below the current anchor, implying limited near‑term upside absent positive trial or partnership news [#SERP-1]. Overall tone is cautious; the stock remains highly sensitive to binary clinical and funding catalysts [#SERP-5].
RankAlpha Sentiment AI - 2026-03-07
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-06-05eventPartnership, licensing, or M&A interestHigh impact
Potential partnership or acquisition interest could surface within months; no public window disclosed, assumed conservative near-term window end for modeling purposes (assumption noted) [#SERP-3].
2026-06-05catalystNear-term analyst target revisions and sentimentHigh impact
Recent analyst activity and target updates (e.g., MarketBeat note and consensus pages) may drive price re-rating over the next quarter; watch for further target updates and notes that could lower consensus toward the median [#SERP-3], [#SERP-1].
2027-03-07catalystPipeline clinical-data readouts or milestone updatesHigh impact
Positive late-stage or exploratory trial readouts and milestone progress would materially re-rate value over a longer horizon; absence or negative outcomes would amplify downside risk (biotech binary) [#SERP-5].
Recommendation
N/A
No formal recommendation provided.
As of 2026-03-07 • Updated nightlySource: Internal modelMethodology